25
September

09:00 AM CEST

How Can Technology Bridge Silos within Drug Discovery?

Name: Chemaxon - How Can Technology Bridge Silos within Drug Discovery?
Start: 2024-09-25T08:00
End: 2024-09-25T18:00
Location: Hotel Pullman Basel Europe Clarastrasse 43 4058 Basel, Switzerland

Hotel Pullman Basel Europe Clarastrasse 43 4058 Basel, Switzerland

What to expect

Timely information, interactive format

The first ever ChemTalks is a step up from our user group meetings to a full-fledged scientific conference in Basel, on the 25th of September 2024. In a free, one-day live event we bring you insight from renowned industry experts on using technology to bridge silos in early stage drug discovery, provide a sneak peek into Chemaxon’s product updates, and make sure you have lots of networking opportunities.

Why you should attend

All talks will cover the topic of using technology to connect silos in chemical research – this has been our focus for years. Peek into Chemaxon’s product roadmap, learn about upcoming updates early, and consult with our experts and scientists. Get access to the brightest minds of the industry and take the presentation materials home – all free of charge.

Our Agenda

See Which Topics Are Discussed

Our Speakers

Karl-Heinz Baringhaus

Site Director R&D Frankfurt Sanofi

Nessa Carson

Associate Principal Scientist, Digital Champion AstraZeneca

Josef Eiblmaier

Head of Research, Discovery and Pre-Clinical, PharmaLex a Cencora company

Peter Ertl

Formerly Director of Cheminformatics, Biomedical Research Novartis

Peter Ertl studied organic chemistry and received his PhD at the University of Bratislava. Then he joined Ciba-Geigy in Basel as a molecular modeler. After a merger with Sandoz to form Novartis, he became Head of the Cheminformatics group in Pharma Research, responsible for development of new methods for calculation of molecular properties and cheminformatics web tools for medicinal chemists.
Peter is author of more than 130 publications covering all areas of cheminformatics and computational chemistry. His major research interests include analysis and visualization of chemical space, bioisosteric design and interactive web tools supporting the work of medicinal chemists.
In the cheminformatics community Peter is known as the author of several cheminformatics algorithms that have become industry standards, including a fast fragment based method to calculate molecular polar surface area and methods to calculate synthetic accessibility or natural-products likeness of molecules.

Jeremy Frey

Head Computational Systems Chemistry University of Southampton

Thrasyvoulos Karydis

Co-founder, Chief Technology Officer DeepCure

Jessica Lanini

Senior Expert, Data Science, Novartis Institutes BioMedical Research

Timur Madzhidov

Senior Product Manager in Chemistry Innovation Elsevier

Adrian Stevens

Chief Product Office Chemaxon

Becky Upton

President Pistoia Alliance

Becky Upton was appointed as the Pistoia Alliance’s first female President in June 2022. She is a long-time supporter of pre-competitive collaboration in life sciences and healthcare R&D and the critical role it plays in advancing science and is passionate about diversity in STEM. Becky is responsible for leading the Pistoia Alliance’s strategy and defining its future within areas of increasing importance to the industry, such as data standards, emerging technologies, diversity and inclusion, sustainability, and precision medicine. 
Becky first engaged with the Pistoia Alliance on its Lab of the Future project whilst at VWR (now part Avantor) where she worked for over a decade in sales, business development, and scientific services. From here, she joined the scientific instrumentation and analytical services company, Pion, as Managing Director, before moving to the Alliance as a project manager. She later became Chief Portfolio Officer and within this role established the Alliance’s first and thriving Diversity and Inclusion in STEM Leadership program. Becky re-joined the Alliance as President after a return to the commercial world as a Director at Impellam Group where she led the company’s STEM services strategy.
Becky has a PhD in Biochemistry from Imperial College and an MBA from Cranfield University.

Register Now

As ChemTalks is hosted in person, attendance is limited. We want to make sure your experience with us is relevant. We will confirm each registered guest individually. Please check your inbox for the confirmation e-mail.

*To be eligible to attend, you must be from a drug development company that has a current and public drug pipeline.

*First name

*Last name

*Company name

*Job Title

*First line of address

*City

*Postcode/Zipcode

*Country

*Work Email

*Direct Line

*Mobile/Cell

*What are your 3 main strategic challenges?

***We Highly Recommend to Use Google Chrome, Safari or Firefox Browser.

I hereby consent Proventa International to collect and share my provided contact details to other delegates and sponsors attending the same event I am attending.

I agree to Proventa International using this information to contact me about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy.

More about ChemAxon

More information

Scientific curiosity, customer collaboration, and technical innovation are all part of Chemaxon’s DNA. Chemaxon was founded in 1998 by Ferenc Csizmadia. Back then, we had one simple goal: to advance science with tools that were accessible from anywhere. This goal inspired our flagship product, Marvin, which was the first chemical drawing software you could use in a browser.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

14 May 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting East Coast USA 2024

21 May 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting West Coast USA 2024

16 May 2024

Clinical Operations and Clinical Trial Supply Chain Strategy Meeting East Coast USA 2024

23 May 2024

Clinical Operations and Clinical Trial Supply Chain Strategy Meeting West Coast USA 2024

15 May 2024

Medicinal Chemistry Strategy Meeting East Coast USA 2024

22 May 2024

Medicinal Chemistry Strategy Meeting West Coast USA 2024

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D Chemaxon

Chemaxon Innovation Spotlight : Celebrating 25 years of innovation in drug discovery

How Can Technology Bridge Silos within Drug Discovery?

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2012%2016'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Hotel Pullman Basel Europe Clarastrasse 43 4058 Basel, Switzerland

Timely information, interactive format

Why you should attend

Our Agenda

See Which Topics Are Discussed

WELCOME NOTE Richard Jones, CEO, Chemaxon

Unlocking the power of data from disparate sources: Elsevier’s journey toward accurate reaction outcome predictions Timur Madzhidov, Senior Product Manager in Chemistry Innovation, Elsevier

The beauty of heterogeneity versus the need for standardization: Enabling trusted data consumption in a multi-source, multiownership data landscape Josef Eiblmaier, Head of Research, Discovery and Pre-Clinical, PharmaLex, a Cencora company

Grasping opportunities for better drug discovery: Interdisciplinarity, deeper insights into disease, new technologies and better decision-making Karl-Heinz Baringhaus, Site Director R&D Frankfurt, Sanof

Ontologies in Pharma: The landscape, pre-competitive development, and use-cases Becky Upton, President, Pistoia Alliance

LUNCH AND TECH CORNER BREAK

AFTERNOON SESSION FROM 2PM

AI advancing drug discovery research in the pharmaceutical industry and academia Jessica Lanini, Senior Expert, Data Science, Novartis Institutes for BioMedical Research

AI-driven drug discovery beyond kinases: How to NOT get trapped in a local minimum when designing drugs for intractable targets Thrasyvoulos Karydis, Co-founder, Chief Technology Officer, DeepCure

The magic rings: Navigation in the ring chemical space guided by the bioactive rings Peter Ertl, Formerly Director of Cheminformatics, Biomedical Research, Novartis

Developing new science and technologies that aid future drug discovery needs Adrian Stevens, Chief Product Officer, Chemaxon

How not to waste a chemist’s time: Chemical insights through great user experience Nessa Carson, Associate Principal Scientist, Digital Champion, AstraZeneca

Digital chemistry: Paradigm shift, cultural evolution or business as usual Jeremy Frey, Head Computational Systems Chemistry, University of Southampton

COCKTAIL PARTY

More info coming soon…

Our Speakers

Karl-Heinz Baringhaus

Nessa Carson

Josef Eiblmaier

Peter Ertl

Jeremy Frey

Thrasyvoulos Karydis

Jessica Lanini

Timur Madzhidov

Adrian Stevens

Becky Upton

Register Now

You had been successfully registered.

More about ChemAxon

Further Information

Here To Help

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

14
May
2024

21
May
2024

16
May
2024

23
May
2024

15
May
2024

22
May
2024

Hotel Pullman Basel Europe Clarastrasse 43 4058 Basel, Switzerland